Rasanen P, Roine E, Sintonen H, Semberg-Konttinen V, Ryynanen OP, Roine R: Use of quality-adjusted life years for the estimation of effectiveness of health care: a systematic literature review. Int J Technol Assess Health Care 2006, 22: 235–241.
Article
PubMed
Google Scholar
National Institute for Health and Clinical Excellence: Guide to the methods of technology appraisal 2013. 2013. Available at http://www.nice.org.uk/media/D45/1E/GuideToMethodsTechnologyAppraisal2013.pdf (accessed 12th April 2013)
Google Scholar
Brazier JE, Yang Y, Tsuchiya A, Rowen DL: A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ 2010, 11: 215–225. 10.1007/s10198-009-0168-z
Article
PubMed
Google Scholar
Round J: Capturing information loss in estimates of uncertainty that arise from mapping algorithms. Aberdeen: Presented at the Health Economics Study Group (HESG) meeting, Summer 2008; 2008.
Google Scholar
Mortimer D, Segal L: Comparing the incomparable? A systematic review of competing techniques for converting descriptive measures of health status into QALY-weights. Med Decis Making 2008, 28: 66–89.
Article
PubMed
Google Scholar
Longworth L, Rowen D: Mapping to obtain EQ-5D utility values for use in NICE health technology assessments. Value Health 2013, 16: 202–210. 10.1016/j.jval.2012.10.010
Article
PubMed
Google Scholar
Lin FJ, Longworth L, Pickard AS: Evaluation of content on EQ-5D as compared to disease-specific utility measures. Qual Life Res 2013, 22: 853. 10.1007/s11136-012-0207-6
Article
PubMed
Google Scholar
Stein K, Fry A, Round A, Milne R, Brazier J: What value health? A review of health state values used in early technology assessments for NICE. Appl Health Econ Health Policy 2005, 4: 219–228. 10.2165/00148365-200504040-00004
Article
PubMed
Google Scholar
Ades AE, Lu G, Madan JJ: Which health-related quality-of-life outcome when planning randomized trials: disease-specific or generic, or both? A common factor model. Value Health 2013, 16: 185–194. 10.1016/j.jval.2012.09.012
Article
CAS
PubMed
Google Scholar
Borchani H, Bielza C, Marti Nez-Marti NP, Larranaga P: Markov blanket-based approach for learning multi-dimensional bayesian network classifiers: an application to predict the European quality of life-5 dimensions (EQ-5D) from the 39-item Parkinson’s disease questionnaire (PDQ-39). J Biomed Inform 2012, 45: 1175–1184. 10.1016/j.jbi.2012.07.010
Article
PubMed
Google Scholar
Briggs AH, Bousquet J, Wallace MV, Busse WW, Clark TJ, Pedersen SE, Bateman ED: Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy 2006, 61: 531–536. 10.1111/j.1398-9995.2006.01038.x
Article
CAS
PubMed
Google Scholar
Chancellor JV, Coyle D, Drummond MF: Constructing health state preference values from descriptive quality of life outcomes: mission impossible? Qual Life Res 1997, 6: 159–168.
Article
CAS
PubMed
Google Scholar
Choi HK, Michaud K, Wolfe F: Utility measures in rheumatic disorders. Arthritis Rheum 2002, 46: S76.
Google Scholar
Chuang LH, Kind P: Converting the SF-12 into the EQ-5D: an empirical comparison of methodologies. Pharmacoeconomics 2009, 27: 491–505. 10.2165/00019053-200927060-00005
Article
PubMed
Google Scholar
Clayson DJ, Briggs AH, Sculpher M, De Hert M: Mapping utility scores from the EQ-5D and SF-6D onto the schizophrenia quality of life scale. Value Health 2004, 7: 277.
Article
Google Scholar
Fryback DG, Palta M, Cherepanov D, Bolt D, Kim JS: Comparison of 5 health-related quality-of-life indexes using item response theory analysis. Med Decis Making 2010, 30: 5–15. 10.1177/0272989X09347016
Article
PubMed Central
PubMed
Google Scholar
Kuspinar A, Mayo NE: Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis? Health Qual Life Outcomes 2013, 11: 71. 10.1186/1477-7525-11-71
Article
PubMed Central
PubMed
Google Scholar
Le QA, Doctor JN: Probabilistic mapping of descriptive health status responses onto health state utilities using Bayesian networks: an empirical analysis converting SF-12 into EQ-5D utility index in a national US sample. Med Care 2011, 49: 451–460. 10.1097/MLR.0b013e318207e9a8
Article
PubMed
Google Scholar
Lu G, Brazier JE, Ades AE: Mapping from disease-specific to generic health-related quality-of-life scales: a common factor model. Value Health 2013, 16: 177–184. 10.1016/j.jval.2012.07.003
Article
PubMed
Google Scholar
McEwan P, Kind P, Dixon S, Currie CJ: Using an artificial neural network to predict utility scores from SF-36 data. Value in Health 2004, 7: 305.
Article
Google Scholar
McEwan P, Morrissey M, Currie CJ: PMD30: an improved model to calculate utility scores from SF-36 data. Value in Health 2003, 6: 302–303.
Article
Google Scholar
Woolacott N, Hawkins N, Mason A, Kainth A, Khadjesari Z, Vergel YB, Misso K, Light K, Chalmers R, Sculpher M, Riemsma R: Etanercept and efalizumab for the treatment of psoriasis: a systematic review. Health Technol Assess 2006, 10: 1–233. i-iv
CAS
PubMed
Google Scholar
National Institute for Health and Clinical Excellence: Guide to the methods of technology appraisal. 2008. Available at (accessed 13th July 2010) http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf
Google Scholar
Longworth L, Rowen D: NICE DSU technical support document 10: the use of mapping methods to estimate health state utility values. Sheffield: Decision Support Unit, ScHARR, University of Sheffield; 2011. (Accessed 21st December 2012) http://www.nicedsu.org.uk/TSD%2010%20mapping%20FINAL.pdf
Google Scholar
Poole CD, Connolly MP, Nielsen SK, Currie CJ, Marteau P: A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitis. J Crohns Colitis 2010, 4: 275–282. 10.1016/j.crohns.2009.11.010
Article
PubMed
Google Scholar
Longworth L: Estimating quality adjusted life years where health-related utility data are missing. Uxbridge, UK: PhD thesis Brunel University; 2007.
Google Scholar
Dakin H, Gray A, Murray D: Mapping analyses to estimate EQ-5D utilities and responses based on Oxford knee score. Qual Life Res 2013, 22: 683–694. 10.1007/s11136-012-0189-4
Article
PubMed Central
PubMed
Google Scholar
Edlin R, Tsuchiya A, Brazier J Report to Novartis contact authors for further details. Mapping the Minnesota living with heart failure questionnaire to the EQ-5D index 2002.
Google Scholar
Gray AM, Rivero-Arias O, Clarke PM: Estimating the association between SF-12 responses and EQ-5D utility values by response mapping. Med Decis Making 2006, 26: 18–29. 10.1177/0272989X05284108
Article
PubMed
Google Scholar
Gu NY, Bell C, Botteman MF, Ji X, Carter JA, van Hout B: Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores. Patient 2012, 5: 185–197.
PubMed
Google Scholar
Hernández Alava M, Wailoo A, Wolfe F, Michaud K: A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes. Sheffield, UK: University of Sheffield; 2012. HEDS Discussion Paper (accessed 3rd December 2012) http://www.nicedsu.org.uk/Mapping%20of%20EQ-5D.DP.pdf
Google Scholar
Kaambwa B, Billingham L, Bryan S: Mapping utility scores from the Barthel index. Eur J Health Econ 2013, 14: 231–241. 10.1007/s10198-011-0364-5
Article
PubMed
Google Scholar
Madan J, Khan K, Lamb SE, Petrou S: A comparison of Bayesian and frequentist approaches for mapping between the Roland Morris disability questionnaire and generic preference-based measures. Exeter, UK: Presented at the Health Economics Study Group (HESG) meeting, January 2013; 2013.
Google Scholar
McKenzie L, van der Pol M: Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data. Value Health 2009, 12: 167–171. 10.1111/j.1524-4733.2008.00405.x
Article
PubMed
Google Scholar
Pinedo-Villanueva RA, Turner D, Judge A, Raftery JP, Arden NK: Mapping the Oxford hip score onto the EQ-5D utility index. Qual Life Res 2013, 22: 665–675. 10.1007/s11136-012-0174-y
Article
PubMed
Google Scholar
Rivero-Arias O, Ouellet M, Gray A, Wolstenholme J, Rothwell PM, Luengo-Fernandez R: Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome. Med Decis Making 2010, 30: 341–354. 10.1177/0272989X09349961
Article
PubMed
Google Scholar
Tsuchiya A, Brazier J, McColl E, Parkin D: A condition-specific instrument, a generic instrument, and a preference based generic instrument. Denmark: Presented at the 17th Plenary Meeting of the EuroQoL Group in Copenhagen; 2001.
Google Scholar
van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard AS: Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 2012, 15: 708–715. 10.1016/j.jval.2012.02.008
Article
PubMed
Google Scholar
Young MK, Ng SK, Mellick G, Scuffham PA: Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson’s disease. Qual Life Res 2013, 22: 1065–1072. 10.1007/s11136-012-0231-6
Article
PubMed
Google Scholar
Huang IC, Frangakis C, Atkinson MJ, Willke RJ, Leite WL, Vogel WB, Wu AW: Addressing ceiling effects in health status measures: a comparison of techniques applied to measures for people with HIV disease. Health Serv Res 2008, 43: 327–339.
Article
PubMed Central
PubMed
Google Scholar
Hernández Alava M, Wailoo AJ, Ara R: Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values. Value Health 2012, 15: 550–561. 10.1016/j.jval.2011.12.014
Article
PubMed
Google Scholar
Hernández Alava M, Wailoo A, Wolfe F, Michaud K: The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis. Rheumatology (Oxford) 2013, 52: 944–950. 10.1093/rheumatology/kes400
Article
Google Scholar
Young T, Mukuria C, Rowen D, Brazier J, Longworth L Presented at the 9th World Congress of the International Health Economics Association in Sydney Australia in July 2013. Direct mapping to the EQ-5D index: what is the appropriate model?
Google Scholar
Jia H, Zack MM, Moriarty DG, Fryback DG: Predicting the EuroQol Group’s EQ-5D index from CDC’s “healthy days” in a US sample. Med Decis Making 2011, 31: 174. 10.1177/0272989X10364845
Article
PubMed
Google Scholar
Wolfe F, Michaud K, Wallenstein G: Scale characteristics and mapping accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in patients with rheumatoid arthritis. J Rheumatol 2010, 37: 1615–1625. 10.3899/jrheum.100043
Article
PubMed
Google Scholar
Dams J, Klotsche J, Bornschein B, Reese JP, Balzer-Geldsetzer M, Winter Y, Schrag A, Siderowf A, Oertel WH, Deuschl G, et al.: Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson’s disease. Health Qual Life Outcomes 2013, 11: 35. 10.1186/1477-7525-11-35
Article
PubMed Central
PubMed
Google Scholar
Parker M, Haycox A, Graves J: Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practice. Pharmacoeconomics 2011, 29: 719–730. 10.2165/11588360-000000000-00000
Article
PubMed
Google Scholar
Rowen D, Brazier J, Roberts J: Mapping SF-36 onto the EQ-5D index: how reliable is the relationship? Health Qual Life Outcomes 2009, 7: 27. 10.1186/1477-7525-7-27
Article
PubMed Central
PubMed
Google Scholar
Soini EJ, Hallinen TA, Puolakka K, Vihervaara V, Kauppi MJ: Cost-effectiveness of adalimumab, etanercept, and tocilizumab as first-line treatments for moderate-to-severe rheumatoid arthritis. J Med Econ 2012, 15: 340–351. 10.3111/13696998.2011.649327
Article
CAS
PubMed
Google Scholar
Wu EQ, Mulani P, Farrell MH, Sleep D: Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients. Value Health 2007, 10: 408–414. 10.1111/j.1524-4733.2007.00195.x
Article
PubMed
Google Scholar
Rowen D, Brazier J, Tsuchiya A, Alava MH: Valuing states from multiple measures on the same visual analogue sale: a feasibility study. Health Econ 2012, 21: 715. 10.1002/hec.1740
Article
PubMed
Google Scholar
Richardson J, Iezzi A, Khan M, Maxwell A: Cross-national comparison of twelve quality of life instruments, MIC Paper 2. Australia: Monash Centre for Health Economics Research Paper 78; 2012. (accessed 18th July 2013) http://www.buseco.monash.edu.au/centres/che/che-publications.html
Google Scholar